Clinical Trial Report: TMC278 (Rilpivirine) Versus Efavirenz as Initial Therapy in Treatment-Naïve, HIV-1-Infected Patients
Curr Infect Dis Rep
.
2011 Feb;13(1):1-3.
doi: 10.1007/s11908-010-0148-6.
Author
Rodger D Macarthur
1
Affiliation
1
Division of Infectious Diseases, Wayne State University, 4201 St. Antoine, UHC 7D, Detroit, MI, 48201, USA, rmacarthur@med.wayne.edu.
PMID:
21308448
DOI:
10.1007/s11908-010-0148-6
No abstract available